Keith Speights
TMFFishBiz
Keith Speights is a contributing Motley Fool healthcare analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, technology, and marijuana. Prior to The Motley Fool, Keith was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.
Recent Articles by Keith Speights

Dec 20, 2024
by Keith Speights
3 Stocks That Could Turn $1,000 into $5,000 by 2030

Dec 18, 2024
by Keith Speights
3 No-Brainer Biotech Stocks to Buy With $200 Right Now

Dec 12, 2024
by Keith Speights
The Ultimate Biotech Stock to Buy With $500 Right Now
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.